Paradigm received a favorable Medicare determination by Cahaba Government Benefit Administrators, a contractor with the Centers for Medicare and Medicaid Services, for the post-decompression and motion preserving interlaminar stabilization device.
The Coflex received FDA PMA approval at the end of 2012, and reached a favorable Medicare determination for use as a non-fusion alternative for symptomatic spinal stenosis.
More Articles on Devices:
Drug-Device Combination Market to Reach $30.5B by 2017
InspireMD Names Alan Milinazzo President, CEO
Soft Tissue Regeneration Receives Market Approval for Rotator Cuff Repair Device
